Login / Signup

Increased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer.

Jing ChenPusheng YangShaojing LiYichen Feng
Published in: Journal of immunology research (2023)
Our present study discovered a novel role of FOXM1 in EC, suggesting FOXM1 could be treated as a potential prognostic biomarker and immunotherapeutic target in EC diagnosis and treatment.
Keyphrases
  • endometrial cancer
  • poor prognosis
  • binding protein
  • risk assessment
  • newly diagnosed